Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinji Liangxue mixture is a Traditional Chinese Medicine (TCM) herbal formulation primarily developed for the treatment of hemorrhagic internal hemorrhoids. Based on the classical TCM formula 'Qin Jiao Liang Xue Tang' (Gentiana Macrophylla Blood-Cooling Decoction), the mixture is designed to clear heat, cool the blood, and promote hemostasis in the lower burner. It is typically composed of several botanical ingredients, including *Gentiana macrophylla*, *Sophora japonica*, and *Sanguisorba officinalis*, which are traditionally recognized for their anti-inflammatory and hemostatic properties. Clinical research conducted by the Shanghai Municipal Hospital of Traditional Chinese Medicine has utilized advanced imaging techniques, such as ultrasonic elastography, to evaluate the mixture's efficacy in reducing hemorrhoidal bleeding and improving tissue elasticity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qinji Liangxue mixture.